BE814632A - Vaccins vivants contre les affections causees par un adenovirus bovin - Google Patents

Vaccins vivants contre les affections causees par un adenovirus bovin

Info

Publication number
BE814632A
BE814632A BE143988A BE143988A BE814632A BE 814632 A BE814632 A BE 814632A BE 143988 A BE143988 A BE 143988A BE 143988 A BE143988 A BE 143988A BE 814632 A BE814632 A BE 814632A
Authority
BE
Belgium
Prior art keywords
adenovirus
strain
thermosensitive
bovine adenovirus
vaccines
Prior art date
Application number
BE143988A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE814632A publication Critical patent/BE814632A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/235—Adenoviridae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10111—Atadenovirus, e.g. ovine adenovirus D
    • C12N2710/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BE143988A 1973-05-14 1974-05-07 Vaccins vivants contre les affections causees par un adenovirus bovin BE814632A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36021973A 1973-05-14 1973-05-14

Publications (1)

Publication Number Publication Date
BE814632A true BE814632A (fr) 1974-11-07

Family

ID=23417085

Family Applications (1)

Application Number Title Priority Date Filing Date
BE143988A BE814632A (fr) 1973-05-14 1974-05-07 Vaccins vivants contre les affections causees par un adenovirus bovin

Country Status (2)

Country Link
BE (1) BE814632A (fr)
ZA (1) ZA742447B (fr)

Also Published As

Publication number Publication date
ZA742447B (en) 1975-04-30

Similar Documents

Publication Publication Date Title
EP0672116A4 (fr) Mutants de deletion utilises en tant que vaccins contre le cholera.
AU4951196A (en) Vaccines for plague
DK472988D0 (da) Terapeutiske praeparater mod streptokokinfektioner, transformerede vaerter og produkter fremstillet ved genteknologi
NO931133L (no) Legemidler av polyhydroksymetylenderivater, fremgangsmaater for deres fremstilling og anvendelse
SE324208B (fr)
HUP9901035A2 (hu) Idegen DNS-t tartalmazó parapoxvírusok, előállításuk és alkalmazásuk vakcinákban
GB1430711A (en) Live bovine and method ofvaccination using them
NO174032C (no) Fremgangsmåte for fremstilling av en legemiddel-polymer-matriks innbefattende dimenhydrinat som en aktiv bestanddel
ATE354370T1 (de) Inaktivierte immunogene bakterielle ganzzell- zusammensetzungen
ES379641A1 (es) Procedimiento de produccion de antigenos inactivos para preparados farmaceuticos.
BR9205677A (pt) Processo de produçao de uma composiçao de vacina contra infecçao entérica provocada por bactérias de E. COLI enterotoxigenicas, e, processo para evitar a infecçao entérica
GB1441098A (en) Biological preparations
DE3686158D1 (de) Impfstoff gegen mastitis.
DE69510858D1 (de) Mukosale Verabreichung von Pneumokokken-Antigenen
GB1413614A (en) Virus production
ES2079851T3 (es) Uso de il-4 para mejorar la respuesta inmunitaria frente a inmunogenos en vacunas.
AU656525B2 (en) Method of preparation of vaccines, and the use of the vaccines thus prepared
ES2157219T3 (es) Procedimiento de produccion de una vacuna antitetanica.
ATE201448T1 (de) Impfstoffe auf der basis von streptokinase
FR2174745A1 (en) Mixed veterinary vaccine - active against symptomatic and bacterial anthrax
CA1193565A (fr) Methode de preparation d'un immunogene de pasteurella multocida
DE69833568D1 (de) Isolierte stämme von staphylococcus aureus und daraus hergestellte impfstoffe
FUJINAMI et al. A STUDY ON THE ISOLATION OF THE CYTOPATHIC AGENT FROM MOLLUSCUM CONTAGIOSUM
Renault Study of ribosomal vaccine against experimental staphylococcal skin infection in rabbit.
von Kries et al. Incidence of Haemophilus influenzae infections in Germany between 1992 and 1995

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: SMITHKLINE BECKMAN-ANIMAL HEALTH PRODUCTS S.A.

Effective date: 19940507